Literature DB >> 17541470

Regulation of defense responses against protozoan infection by interleukin-27 and related cytokines.

Hiroki Yoshida1, Yoshiyuki Miyazaki, Sen Wang, Shinjiro Hamano.   

Abstract

Cytokine-mediated immunity is crucial in the defense against pathogens. Recently, IL-23 and IL-27 were identified, which along with IL-12 belong to the IL-12 cytokine family. IL-27 is pivotal for the induction of helper T cell (Th) 1 responses while IL-23 is important for the proliferation of memory type Th1 cells. Recent studies revealed that IL-27 also has an anti-inflammatory property. In some protozoan infection, various proinflammatory cytokines were over produced causing lethal inflammatory responses in IL-27 receptor-deficient mice. The anti-inflammatory effect of IL-27 depends, at least partly, on inhibition of the development of Th17 cells, a newly identified Th population that is induced by IL-23 and is characterized by the production of the inflammatogenic cytokine, IL-17. IL-27 thus has a double identity as an initiator and as an attenuator of immune responses and inflammation. With the discoveries of the new IL-12-related cytokines and Th17 cells, Th development is facing a new paradigm.

Entities:  

Year:  2007        PMID: 17541470      PMCID: PMC1874674          DOI: 10.1155/2007/79401

Source DB:  PubMed          Journal:  J Biomed Biotechnol        ISSN: 1110-7243


  65 in total

1.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

2.  Alternatively activated macrophages express the IL-27 receptor alpha chain WSX-1.

Authors:  Dominik Rückerl; Manuela Hessmann; Takayuki Yoshimoto; Stefan Ehlers; Christoph Hölscher
Journal:  Immunobiology       Date:  2006-07-05       Impact factor: 3.144

3.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

4.  Development of Th1-type immune responses requires the type I cytokine receptor TCCR.

Authors:  Q Chen; N Ghilardi; H Wang; T Baker; M H Xie; A Gurney; I S Grewal; F J de Sauvage
Journal:  Nature       Date:  2000-10-19       Impact factor: 49.962

5.  IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis.

Authors:  Yutaka Komiyama; Susumu Nakae; Taizo Matsuki; Aya Nambu; Harumichi Ishigame; Shigeru Kakuta; Katsuko Sudo; Yoichiro Iwakura
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

6.  Interleukin-27R (WSX-1/T-cell cytokine receptor) gene-deficient mice display enhanced resistance to leishmania donovani infection but develop severe liver immunopathology.

Authors:  Lucia E Rosas; Anjali A Satoskar; Kimberly M Roth; Tracy L Keiser; Joseph Barbi; Christopher Hunter; Frederic J de Sauvage; Abhay R Satoskar
Journal:  Am J Pathol       Date:  2006-01       Impact factor: 4.307

Review 7.  Targeting cytokines of the interleukin-12 family in autoimmunity.

Authors:  Bok Yun Kang; Tae Sung Kim
Journal:  Curr Med Chem       Date:  2006       Impact factor: 4.530

8.  Cutting edge: early IL-4 production governs the requirement for IL-27-WSX-1 signaling in the development of protective Th1 cytokine responses following Leishmania major infection.

Authors:  David Artis; Leanne M Johnson; Karen Joyce; Christiaan Saris; Alejandro Villarino; Christopher A Hunter; Phillip Scott
Journal:  J Immunol       Date:  2004-04-15       Impact factor: 5.422

9.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.

Authors:  Marc Veldhoen; Richard J Hocking; Christopher J Atkins; Richard M Locksley; Brigitta Stockinger
Journal:  Immunity       Date:  2006-02       Impact factor: 31.745

10.  A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.

Authors:  Caroline Sutton; Corinna Brereton; Brian Keogh; Kingston H G Mills; Ed C Lavelle
Journal:  J Exp Med       Date:  2006-07-03       Impact factor: 14.307

View more
  3 in total

1.  Preventive effect of pidotimod on reactivated toxoplasmosis in mice.

Authors:  Xing-Xing Huo; Lin Wang; Zhao-Wu Chen; He Chen; Xiu-Cai Xu; Ai-Mei Zhang; Xiao-Rong Song; Qing-Li Luo; Yuan-Hong Xu; Yu Fu; Hua Wang; Jian Du; Yi-Hong Cai; Zhao-Rong Lun; Fang-Li Lu; Yong Wang; Ji-Long Shen
Journal:  Parasitol Res       Date:  2013-06-18       Impact factor: 2.289

2.  New drugs targeting Th2 lymphocytes in asthma.

Authors:  Gaetano Caramori; David Groneberg; Kazuhiro Ito; Paolo Casolari; Ian M Adcock; Alberto Papi
Journal:  J Occup Med Toxicol       Date:  2008-02-27       Impact factor: 2.646

3.  Transcriptional Profiling of Immune-Related Genes in Leishmania infantum-Infected Mice: Identification of Potential Biomarkers of Infection and Progression of Disease.

Authors:  Eduardo Ontoria; Yasmina E Hernández-Santana; Ana C González-García; Manuel C López; Basilio Valladares; Emma Carmelo
Journal:  Front Cell Infect Microbiol       Date:  2018-06-26       Impact factor: 5.293

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.